Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | IMC-P115C |
| Synonyms | |
| Therapy Description |
Limited information is currently available on IMC-P115C, a putative soluble T-cell receptor (TCR) targeting CD3 and PRAME (Sep 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| IMC-P115C | IMCP115C|IMC P115C | Limited information is currently available on IMC-P115C, a putative soluble T-cell receptor (TCR) targeting CD3 and PRAME (Sep 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07156136 | Phase I | IMC-P115C | Study of IMC-P115C in Advanced PRAME-Positive Cancers | Recruiting | ITA | FRA | ESP | AUS | 0 |